Neisseria Meningitidis Infections Pipeline Review, H1 2016 - 12 Companies & Their Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Neisseria meningitidis Infections - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Neisseria Meningitidis Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Neisseria Meningitidis Infections and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Neisseria Meningitidis Infections Overview
  3. Therapeutics Development
  4. Pipeline Products for Neisseria Meningitidis Infections - Overview
  5. Pipeline Products for Neisseria Meningitidis Infections - Comparative Analysis
  6. Neisseria Meningitidis Infections - Therapeutics under Development by Companies
  7. Neisseria Meningitidis Infections - Therapeutics under Investigation by Universities/Institutes
  8. Neisseria Meningitidis Infections Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Neisseria Meningitidis Infections - Products under Development by Companies
  13. Neisseria Meningitidis Infections - Products under Investigation by Universities/Institutes
  14. Neisseria Meningitidis Infections - Companies Involved in Therapeutics Development
  • Beijing Minhai Biotechnology Co., Ltd
  • Beijing Tiantan Biological Products Co., Ltd.
  • Biological E. Limited
  • GlaxoSmithKline Plc
  • ImmunoBiology Limited
  • JN-International Medical Corporation
  • MGB Biopharma Limited
  • Panacea Biotec Limited
  • Pfizer Inc.
  • Sanofi Pasteur SA
  • Serum Institute of India Limited
  • Wellstat Vaccines, LLC

For more information visit http://www.researchandmarkets.com/research/b3vgxb/neisseria

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs, Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs, Infectious Diseases Drugs